Malignant Bile Duct Neoplasm — Trials

Malignant Bile Duct Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

883 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 223
Recruiting: 126
Ph III recruiting: 7
Growth YoY: +14.6%
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (119)

clinicaltrialsPublishedShowing 351–370 of 370 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00713687	Gemcitabine/Oxaliplatin and Photodynamic Therapy in Cholangiocarcinoma(GemOx-PDT)	withdrawn	Phase 2	0	Technical University of MunichOTHER	1	Aug 10, 2012	clinicaltrials
NCT00030511	Radiation Therapy and Fluorouracil Before Surgery in Treating Patients With Primary or Recurrent Bile Duct Cancer	terminated	Phase 2	—	European Organisation for Research and Treatment of Cancer - EORTCNETWORK	3